Exenatide (Bydureon, Byetta)

BNF:
6.1.2.3
Status:
Grey
Decision Date:
July 2016
 

Comments

Prescribe by brand. 

GREY by exceptionality defined as intolerance to the preferred 1st line choice or restricted by their licensing.

See local guidance for supporting material for prescribers.

Brown Drug Classifications

  • 6: NICE guidance

search again